Cited by 4Blood transfusion and managementBlood donation and transfusion practicesTrauma, Hemostasis, Coagulopathy, Resuscitation

The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.

Blood, Blood Components, Plasma, and Plasma Products

Kristine A. Sobolewski, Sara Radparvar, Cecilia Wong, Jackie P. Johnston·2018·Side Effects of Drugs Annual

DOI 10.1016/bs.seda.2018.06.011

Open this paper in CoChat — free account

Integrity signals

Registry

Crossref · 10.1016/bs.seda.2018.06.011

Cites

109 of 109 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Acute Graft-versus-Host Disease — Biologic Process, Prevention, and Therapy
Zeiser, R., & Blazar, B. R. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1609337 · Cited by 1,296
Eltrombopag Added to Standard Immunosuppression for Aplastic Anemia
Townsley, D. M., Scheinberg, P., Winkler, T., Desmond, R., Dumitriu, B., Rios, O., Weinstein, B., Valdez, J., Lotter, J., Feng, X., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1613878 · Cited by 562
Safety and Efficacy of the Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Patients With Heart Failure: A Phase 1/2 Randomized Controlled Trial (RIMECARD Trial [Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy])
Bartolucci, J., Verdugo, F. J., González, P. L., Larrea, R. E., Abarzua, E., Goset, C., Rojo, P., Palma, I., Lamich, R., Pedreros, P. A., et al. (2017) · Circulation Research · doi:10.1161/circresaha.117.310712 · Cited by 487
Vision Loss after Intravitreal Injection of Autologous “Stem Cells” for AMD
Kuriyan, A. E., Albini, T. A., Townsend, J. H., Rodriguez, M., Pandya, H. K., Leonard, R. E., Parrott, M. B., Rosenfeld, P. J., Flynn, H. W., & Goldberg, J. L. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1609583 · Cited by 462
Management of rivaroxaban- or apixaban-associated major bleeding with prothrombin complex concentrates: a cohort study
Majeed, A., Ågren, A., Holmström, M., Bruzelius, M., Chaireti, R., Odeberg, J., Hempel, E.-L., Magnusson, M., Frisk, T., & Schulman, S. (2017) · Blood · doi:10.1182/blood-2017-05-782060 · Cited by 326
Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial
van Schaik, I. N., Bril, V., van Geloven, N., et al. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30378-2 · Cited by 281
Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 Inhibitor
Longhurst, H. J., Cicardi, M., Craig, T., Bork, K., Grattan, C. E. H., Baker, J., Li, H., Reshef, A., Bonner, J. R., Bernstein, J. A., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1613627 · Cited by 246
Allogeneic Blood Transfusion Is a Significant Risk Factor for Surgical-Site Infection Following Total Hip and Knee Arthroplasty: A Meta-Analysis
Kim, J. L., Park, J.-H., Han, S.-B., Cho, I. Y., & Jang, K.-M. (2016) · The Journal of Arthroplasty · doi:10.1016/j.arth.2016.08.026 · Cited by 238
Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE)
McElvaney, N. G., BURDON, J. G. W., Holmes, M., et al. (2016) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(16)30430-1 · Cited by 199
Late effects of blood and marrow transplantation
Inamoto, Y., & Lee, S. J. (2017) · Haematologica · doi:10.3324/haematol.2016.150250 · Cited by 179
Eltrombopag versus placebo for low-risk myelodysplastic syndromes with thrombocytopenia (EQoL-MDS): phase 1 results of a single-blind, randomised, controlled, phase 2 superiority trial
Olíva, E. N., Alati, C., Santini, V., Poloni, A., Molteni, A., Niscola, P., Salvi, F., Sanpaolo, G., Balleari, E., Germing, U., et al. (2017) · The Lancet Haematology · doi:10.1016/s2352-3026(17)30012-1 · Cited by 162
Concise Review: A Safety Assessment of Adipose-Derived Cell Therapy in Clinical Trials: A Systematic Review of Reported Adverse Events
Toyserkani, N. M., Jørgensen, M. G., Tabatabaeifar, S., Jensen, C. H., Sheikh, S. P., & Sørensen, J. A. (2017) · Stem Cells Translational Medicine · doi:10.1002/sctm.17-0031 · Cited by 125
The future of mesenchymal stem cell-based therapeutic approaches for cancer – From cells to ghosts
Mohr, A., & Zwacka, R. M. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.11.025 · Cited by 115
Effect of Fibrinogen Concentrate on Intraoperative Blood Loss Among Patients With Intraoperative Bleeding During High-Risk Cardiac Surgery: A Randomized Clinical Trial
Bilecen, S., de Groot, J. A. H., Kalkman, C. J., Spanjersberg, A. J., Bruinsma, G. J. B. B., Moons, K. G. M., & Nierich, A. P. (2017) · JAMA · doi:10.1001/jama.2016.21037 · Cited by 110
No Benefit From Platelet Transfusion for Gastrointestinal Bleeding in Patients Taking Antiplatelet Agents
Zakko, L., Rustagi, T., Douglas, M., & Laine, L. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2016.07.017 · Cited by 99
Zika Virus Infection and Prolonged Viremia in Whole-Blood Specimens
Mansuy, J., Mengelle, C., Pasquier, C., et al. (2017) · Emerging infectious diseases · doi:10.3201/eid2305.161631 · Cited by 97
Intravitreal injection of bone marrow mesenchymal stem cells in patients with advanced retinitis pigmentosa; a safety study
Ahmadieh, H., Baharvand, H., Satarian, L., Nourinia, R., Safi, S., Kanavi, M. R., Jarughi, N., Daftarian, N., Arab, L., & Aghdami, N. (2017) · Journal of Ophthalmic and Vision Research · doi:10.4103/2008-322x.200164 · Cited by 93
Red blood cell transfusions can induce proinflammatory cytokines in preterm infants
Dani, C., Poggi, C., Gozzini, E., et al. (2017) · Transfusion · doi:10.1111/trf.14080 · Cited by 92
Recombinant factor IX Fc fusion protein in children with haemophilia B (Kids B-LONG): results from a multicentre, non-randomised phase 3 study
Fischer, K., Kulkarni, R., Nolan, B., et al. (2017) · The Lancet Haematology · doi:10.1016/s2352-3026(16)30193-4 · Cited by 87
Extended half‐life pegylated, full‐length recombinant factor VIII for prophylaxis in children with severe haemophilia A
Mullins, E. S., Stasyshyn, O., Alvarez‐Román, M. T., Osman, D., Liesner, R. J., Engl, W., Sharkhawy, M., & Abbuehl, B. E. (2016) · Haemophilia · doi:10.1111/hae.13119 · Cited by 86
Subcutaneous immunoglobulins in patients with multiple myeloma and secondary hypogammaglobulinemia: a randomized trial
Vacca, A., Melaccio, A., Sportelli, A., Solimando, A. G., Dammacco, F., & Ria, R. (2017) · Clinical Immunology · doi:10.1016/j.clim.2017.11.014 · Cited by 83
Benefits and harms of 4-factor prothrombin complex concentrate for reversal of vitamin K antagonist associated bleeding: a systematic review and meta-analysis
Brekelmans, M. P. A., van Ginkel, K., Daams, J. G., Hutten, B. A., Middeldorp, S., & Coppens, M. (2017) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-017-1506-0 · Cited by 69
Is platelet transfusion associated with hospital-acquired infections in critically ill patients?
Aubron, C., Flint, A. W. J., Bailey, M., et al. (2017) · Critical Care · doi:10.1186/s13054-016-1593-x · Cited by 68
Recombinant human C1 esterase inhibitor for prophylaxis of hereditary angio-oedema: a phase 2, multicentre, randomised, double-blind, placebo-controlled crossover trial
Riedl, M. A., Grivcheva‐Panovska, V., Moldovan, D., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31963-3 · Cited by 64
Granulocyte transfusions in the management of invasive fungal infections
West, K. A., Gea‐Banacloche, J., Stroncek, D. F., & Kadri, S. S. (2017) · British Journal of Haematology · doi:10.1111/bjh.14597 · Cited by 61
Acute Kidney Injury in Pediatric Patients Receiving Allogeneic Hematopoietic Cell Transplantation: Incidence, Risk Factors, and Outcomes
Koh, K., Sunkara, A., Kang, G., et al. (2017) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2017.11.021 · Cited by 60
Stem cell transplantation for spinal cord injury: a meta-analysis of treatment effectiveness and safety
Li, Z., Fan, X. L., Wang, J.-Z., & Lin, X. (2017) · Neural Regeneration Research · doi:10.4103/1673-5374.206653 · Cited by 58
Current Review of Iron Overload and Related Complications in Hematopoietic Stem Cell Transplantation
Atilla, E., Toprak, S. K., & Demirer, T. (2016) · Turkish Journal of Hematology · doi:10.4274/tjh.2016.0450 · Cited by 57
Survival and Late Effects after Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancy at Less than Three Years of Age
Vrooman, L. M., Millard, H. R., Brazauskas, R., et al. (2017) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2017.04.017 · Cited by 57
Efficacy, safety, tolerability and pharmacokinetics of a novel human immune globulin subcutaneous, 20%: a Phase 2/3 study in Europe in patients with primary immunodeficiencies
Borte, M., Kriván, G., Dérfalvi, B., Maródi, L., Harrer, T., Jolles, S. R. A., Bourgeois, C., Engl, W., Leibl, H., McCoy, B., et al. (2016) · Clinical & Experimental Immunology · doi:10.1111/cei.12866 · Cited by 56
Bilateral Retinal Detachments After Intravitreal Injection of Adipose-Derived ‘Stem Cells’ in a Patient With Exudative Macular Degeneration
Saraf, S. S., Cunningham, M. A., Kuriyan, A. E., Read, S. P., Rosenfeld, P. J., Flynn, H. W., & Albini, T. A. (2017) · Ophthalmic surgery, lasers & imaging retina · doi:10.3928/23258160-20170829-16 · Cited by 52
Subcutaneous immunoglobulin in myasthenia gravis exacerbation: A prospective, open-label trial
Beecher, G., Anderson, D., & Siddiqi, Z. A. (2017) · Neurology · doi:10.1212/wnl.0000000000004365 · Cited by 51
An Objective Measure of Splitting in Parental Alienation: The Parental Acceptance–Rejection Questionnaire
Bernet, W., Gregory, N. Ö., Reay, K. M., et al. (2017) · Journal of Forensic Sciences · doi:10.1111/1556-4029.13625 · Cited by 49
Reduction of DMSO concentration in cryopreservation mixture from 10% to 7.5% and 5% has no impact on engraftment after autologous peripheral blood stem cell transplantation: results of a prospective, randomized study
Mitrus, I., Smagur, A., Fidyk, W., et al. (2017) · Bone Marrow Transplantation · doi:10.1038/s41409-017-0056-6 · Cited by 49
Effect of storage time of platelet products on clinical outcomes after transfusion: a systematic review and meta‐analyses
Kreuger, A. L., Caram‐Deelder, C., Jacobse, J., et al. (2017) · Vox Sanguinis · doi:10.1111/vox.12494 · Cited by 45
Risk and prognostic factors of transplantation‐associated thrombotic microangiopathy in allogeneic haematopoietic stem cell transplantation: a nested case control study
Ye, Y., Zheng, W., Wang, J., et al. (2016) · Hematological Oncology · doi:10.1002/hon.2310 · Cited by 44
Association of Intraoperative Blood Transfusions on Postoperative Complications, 30-Day Readmission Rates, and 1-Year Patient-Reported Outcomes
Elsamadicy, A., Adogwa, O., Vuong, V. D., Mehta, A. I., Vasquez, R. A., Cheng, J. S., Bagley, C., & Karikari, I. O. (2017) · Spine · doi:10.1097/brs.0000000000001803 · Cited by 44
Restricted Albumin Utilization Is Safe and Cost Effective in a Cardiac Surgery Intensive Care Unit
Rabin, J., Meyenburg, T., Lowery, A. V., et al. (2016) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2016.10.018 · Cited by 42
Adverse events of cryopreserved hematopoietic stem cell infusions in adults: a single‐center observational study
Otrock, Z. K., Sempek, D. S., Carey, S., et al. (2017) · Transfusion · doi:10.1111/trf.14072 · Cited by 42
Does a Platelet Transfusion Independently Affect Bleeding and Adverse Outcomes in Cardiac Surgery?
van Hout, F. M. A., Hogervorst, E. K., Rosseel, P. M. J., van der Bom, J. G., Bentala, M., van Dorp, E. L. A., van Geloven, N., Brand, A., van der Meer, N. J. M., & van de Watering, L. M. G. (2017) · Anesthesiology · doi:10.1097/aln.0000000000001518 · Cited by 41
Granulocyte transfusions in patients with chronic granulomatous disease and refractory infections: The NIH experience
Marciano, B. E., Allen, E. S., Conry‐Cantilena, C., Kristosturyan, E., Klein, H. G., Fleisher, T. A., Holland, S. M., Malech, H. L., & Rosenzweig, S. D. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.02.026 · Cited by 40
Efficacy and safety of a VWF / FVIII concentrate (wilate®) in inherited von Willebrand disease patients undergoing surgical procedures
Srivastava, A., Şerban, M., Werner, S., et al. (2016) · Haemophilia · doi:10.1111/hae.13106 · Cited by 39
Uses and misuses of albumin during resuscitation and in the neonatal intensive care unit
Shalish, W., Olivier, F., Aly, H. Z., & SantʼAnna, G. (2017) · Seminars in Fetal and Neonatal Medicine · doi:10.1016/j.siny.2017.07.009 · Cited by 38
Safety Analysis of Autologous Stem Cell Therapy in a Variety of Degenerative Diseases and Injuries Using the Stromal Vascular Fraction
Comella, K., Parlo, M., Daly, R., Depasquale, V., Edgerton, E., Mallory, P. J., Schmidt, R., & Drake, W. P. (2017) · Journal of Clinical Medicine Research · doi:10.14740/jocmr3187w · Cited by 36
Side effects of drugs annual : a worldwide yearly survey of new data in adverse drug reactions
Aronson, J. K. (2008) · Cited by 36
Insufficient evidence of benefit regarding mortality due to albumin substitution in HCC‐free cirrhotic patients undergoing large volume paracentesis
Kütting, F., Schubert, J., Franklin, J. G., et al. (2016) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13421 · Cited by 35
Effect of Transfusion on Mortality and Other Adverse Events Among Critically Ill Septic Patients: An Observational Study Using a Marginal Structural Cox Model*
Dupuis, C., Garrouste-Orgeas, M., Bailly, S., Adrie, C., Goldgran-Tolédano, D., Azoulay, É., Ruckly, S., Marcotte, G., Souweine, B., Darmon, M., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002688 · Cited by 35
Low‐factor consumption for major surgery in haemophilia B with long‐acting recombinant glyco PEG ylated factor IX
Escobar, M. A., Tehranchi, R., Karim, F. A., et al. (2016) · Haemophilia · doi:10.1111/hae.13041 · Cited by 34
Long-term safety and efficacy of extended-interval prophylaxis with recombinant factor IX Fc fusion protein (rFIXFc) in subjects with haemophilia B
Pasi, J., Fischer, K., Ragni, M. V., Nolan, B., Perry, D. J., Kulkarni, R., Ozelo, M. C., Mahlangu, J. N., Shapiro, A. D., Baker, R. I., et al. (2016) · Thrombosis and Haemostasis · doi:10.1160/th16-05-0398 · Cited by 34
Allogeneic Bone Marrow-Derived Mesenchymal Stromal Cells Expanded In Vitro for Treatment of Aplastic Anemia: A Multicenter Phase II Trial
Pang, Y., Xiao, H., Zhang, H., Liu, Z., Li, L., Gao, Y., Li, H., Jiang, Z., Tan, H., Lin, J., et al. (2017) · Stem Cells Translational Medicine · doi:10.1002/sctm.16-0227 · Cited by 28
Comparative effectiveness and safety of erythropoiesis-stimulating agents (biosimilars vs originators) in clinical practice: a population-based cohort study in Italy
Trotta, F., Belleudi, V., Fusco, D., et al. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-011637 · Cited by 27
Use of intravenous fluids/solutions: a narrative review
Gkotmi, N. E., Kosmeri, C., Filippatos, T. D., & Elisaf, M. (2016) · Current Medical Research and Opinion · doi:10.1080/03007995.2016.1261819 · Cited by 24
Shift from intravenous or 16% subcutaneous replacement therapy to 20% subcutaneous immunoglobulin in patients with primary antibody deficiencies
Canessa, C., Iacopelli, J., Pecoraro, A., et al. (2016) · International Journal of Immunopathology and Pharmacology · doi:10.1177/0394632016681577 · Cited by 24
Granulocyte Transfusions: A Critical Reappraisal
Valentini, C. G., Farina, F., Pagano, L., & Teofili, L. (2017) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2017.07.029 · Cited by 24
Intraoperative Administration of 4-Factor Prothrombin Complex Concentrate Reduces Blood Requirements in Cardiac Transplantation
Sun, G. H., Patel, V., Moreno‐Duarte, I., et al. (2017) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2017.08.011 · Cited by 23
Efficacy and Long-Term Safety of C.E.R.A. Maintenance in Pediatric Hemodialysis Patients with Anemia of CKD
Fischbach, M., Wühl, E., Reigner, S. M., Morgan, Z., & Schaefer, F. S. (2017) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03570417 · Cited by 23
High dose subcutaneous immunoglobulin for idiopathic inflammatory myopathies and dysimmune peripheral chronic neuropathies treatment: observational study of quality of life and tolerance
HACHULLA, E., Benvéniste, O., Hamidou, M. A., Mouthon, L., SCHLEINITZ, N., Lozeron, P., Léger, J., Vial, C., & Viala, K. (2016) · International Journal of Neuroscience · doi:10.1080/00207454.2016.1204544 · Cited by 22
Hepatitis E Virus Infection after Platelet Transfusion in an Immunocompetent Trauma Patient
Loyrion, E., Trouvé-Buisson, T., Pouzol, P., et al. (2016) · Emerging infectious diseases · doi:10.3201/eid2301.160923 · Cited by 22
Incidence of thromboembolic events after use of gelatin-thrombin-based hemostatic matrix during intracranial tumor surgery
Gazzeri, R., Galarza, M., Conti, C., et al. (2017) · Neurosurgical Review · doi:10.1007/s10143-017-0856-6 · Cited by 22
The effects of storage of red blood cells on the development of postoperative infections after noncardiac surgery
Spadaro, S., Taccone, F. S., Fogagnolo, A., et al. (2017) · Transfusion · doi:10.1111/trf.14249 · Cited by 22
The effect of 6% hydroxyethyl starch (130/0.4) on acute kidney injury in paediatric cardiac surgery: a prospective, randomised trial
Oh, H., Lee, J., Kim, H., Kim, E., Song, I. ‐., Kim, H., & Kim, J. (2017) · Anaesthesia · doi:10.1111/anae.14129 · Cited by 22
MRI-based evaluation of multiorgan iron overload is a predictor of adverse outcomes in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation
Maximova, N., Gregori, M., Boz, G., Simeone, R., Zanon, D., Schillani, G., & Zennaro, F. (2017) · Oncotarget · doi:10.18632/oncotarget.19021 · Cited by 21
The dose of hydroxyethyl starch 6% 130/0.4 for fluid therapy and the incidence of acute kidney injury after cardiac surgery: A retrospective matched study
Momeni, M., Ena, L. N., Dyck, M. V., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186403 · Cited by 21
Drug‐induced cutaneous lupus erythematosus after immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a case series
Adrichem, M. E., Starink, M. V., van Leeuwen, E. M. M., Krämer, C., van Schaik, I. N., & Eftimov, F. (2017) · Journal of the Peripheral Nervous System · doi:10.1111/jns.12218 · Cited by 20
Comparative efficacy and safety in ESA biosimilars vs. originators in adults with chronic kidney disease: a systematic review and meta-analysis
Amato, L., Addis, A., Saulle, R., et al. (2017) · Journal of Nephrology · doi:10.1007/s40620-017-0419-5 · Cited by 20
Recombinant porcine factor VIII for high‐risk surgery in paediatric congenital haemophilia A with high‐titre inhibitor
Croteau, S. E., Abajas, Y. L., Wolberg, A. S., et al. (2017) · Haemophilia · doi:10.1111/hae.13157 · Cited by 19
SANGUINATE™ (PEGylated Carboxyhemoglobin Bovine) Improves Cerebral Blood Flow to Vulnerable Brain Regions at Risk of Delayed Cerebral Ischemia After Subarachnoid Hemorrhage
Dhar, R., Misra, H. K., & Diringer, M. N. (2017) · Neurocritical Care · doi:10.1007/s12028-017-0418-3 · Cited by 19
Safety of a pasteurized plasma‐derived Factor VIII and von Willebrand factor concentrate: analysis of 33 years of pharmacovigilance data
Kouides, P. A., Wawra‐Hehenberger, K., Sajan, A., Mead, H., & Simon, T. L. (2017) · Transfusion · doi:10.1111/trf.14241 · Cited by 19
Pharmacokinetics, efficacy, and safety of a plasma-derived VWF/FVIII concentrate (VONCENTO) for on-demand and prophylactic treatment in patients with von Willebrand disease (SWIFT-VWD study)
Lissitchkov, T. J., Иванович, Б. Е., Kuliczkowski, K., Stasyshyn, O., Cerqueira, M., Klukowska, A., Joch, C., & Seifert, W. F. (2016) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0000000000000568 · Cited by 18
Safety of C1-inhibitor concentrate use for hereditary angioedema in pediatric patients
Busse, P. J., Baker, J., Martinez‐Saguer, I., et al. (2017) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2016.12.033 · Cited by 18
Hemolysis related to intravenous immunoglobulins is dependent on the presence of anti‐blood group A and B antibodies and individual susceptibility
Mielke, O., Fontana, S., Goranova-Marinova, V. S., et al. (2017) · Transfusion · doi:10.1111/trf.14289 · Cited by 18
Fresh frozen plasma transfusion – a risk factor for pulmonary hemorrhage in extremely low birth weight infants?
Usemann, J., Garten, L., Bührer, C., et al. (2017) · Journal of Perinatal Medicine · doi:10.1515/jpm-2016-0309 · Cited by 16
Potentially life-threatening coagulopathy associated with simultaneous reduction in coagulation and fibrinolytic function in pediatric acute leukemia after hematopoietic stem-cell transplantation
Ishihara, T., Nogami, K., Matsumoto, T., et al. (2017) · International Journal of Hematology · doi:10.1007/s12185-017-2213-5 · Cited by 16
A randomized multicenter study: safety and efficacy of mini‐pool intravenous immunoglobulin versus standard immunoglobulin in children aged 1‐18 years with immune thrombocytopenia
Elalfy, M. S., Reda, M., Islam, E., et al. (2017) · Transfusion · doi:10.1111/trf.14301 · Cited by 16
Hemoglobin-Based Oxygen Carrier Rescues Double-Transplant Patient From Life-Threatening Anemia
Gomez, M. F., Aljure, O., Ciancio, G., et al. (2017) · American Journal of Transplantation · doi:10.1111/ajt.14226 · Cited by 15
Evaluation of the Safety, Tolerability, and Pharmacokinetics of Gammaplex® 10% Versus Gammaplex® 5% in Subjects with Primary Immunodeficiency
Wasserman, R. L., Melamed, I., Stein, M. R., et al. (2017) · Journal of Clinical Immunology · doi:10.1007/s10875-017-0383-9 · Cited by 15
Effect of Balanced Crystalloid, Gelatin and Hydroxyethyl Starch on Coagulation Detected by Rotational Thromboelastometry In Vitro
Sevcikova, S., Vymazal, T., & Durila, M. (2017) · Clinical Laboratory · doi:10.7754/clin.lab.2017.170505 · Cited by 14
Immediate adverse reactions to intravenous immunoglobulin in children: a single center experience.
Kaba, S., Keskindemirci, G., Aydoğmuş, Ç., et al. (2017) · PubMed · Cited by 13
Surveillance study on the tolerability and safety of Flebogamma ® DIF (10% and 5% intravenous immunoglobulin) in adult and pediatric patients
Alsina, L., Mohr, A., Montañés, M. A. R., et al. (2017) · Pharmacology Research & Perspectives · doi:10.1002/prp2.345 · Cited by 13
Recombinant Human C1-Esterase Inhibitor to Treat Acute Hereditary Angioedema Attacks in Adolescents
Baker, J., Reshef, A., Moldovan, D., et al. (2017) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2016.11.005 · Cited by 12
Gelatin Anaphylaxis During Surgery: A Rare Cause of Perioperative Anaphylaxis
Raveendran, R., & Khan, D. A. (2017) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2017.06.030 · Cited by 12
Facilitated Subcutaneous Immunoglobulin (fSCIg) in Autoimmune Cytopenias Associated with Common Variable Immunodeficiency.
Pedini, V., Savore, I., & Danieli, M. G. (2017) · PubMed · Cited by 12
Effects of 6% hydroxyethyl starch 130/0.4 on postoperative blood loss and kidney injury in off-pump coronary arterial bypass grafting
Min, J. J., Cho, H. S., Jeon, S., et al. (2017) · Medicine · doi:10.1097/md.0000000000006801 · Cited by 11
Comparative treatment-related adverse event cost burden in immune thrombocytopenic purpura
Donga, P. Z., Bilir, S. P., Little, G., et al. (2017) · Journal of Medical Economics · doi:10.1080/13696998.2017.1370425 · Cited by 11
Stem Cell Registry Programme for Patients with Ischemic Cardiomyopathy Undergoing Coronary Artery Bypass Grafting: What Benefits does it Derive?
Nesteruk, J., Voronina, N., Kundt, G., et al. (2017) · ESC Heart Failure · doi:10.1002/ehf2.12132 · Cited by 9
Effects of colloid pre-loading on thromboelastography during elective intracranial tumor surgery in pediatric patients: hydroxyethyl starch 130/0.4 versus 5% human albumin
Peng, Y., Du, J., Zhao, X., et al. (2017) · BMC Anesthesiology · doi:10.1186/s12871-017-0353-z · Cited by 9
The Effects of Hydroxyethyl Starch 6% and Crystalloid on Volume Preloading Changes following Spinal Anesthesia
Saghafinia, M., Jalali, A., Eskandari, M., et al. (2017) · Advanced Biomedical Research · doi:10.4103/abr.abr_151_16 · Cited by 9
Association of hemolysis with high dose intravenous immunoglobulin therapy in pediatric patients: An open-label prospective trial
Akman, A. Ö., Kara, F. K., Köksal, T., et al. (2017) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2017.07.022 · Cited by 8
Passive blood anaphylaxis: subcutaneous immunoglobulins are a cause of ongoing passive anaphylactic reaction
Zdziarski, P., Gamian, A., Majda, J., et al. (2017) · Allergy Asthma and Clinical Immunology · doi:10.1186/s13223-017-0213-x · Cited by 8
Acute renal dysfunction caused by nonsucrose intravenous immunoglobulin in common variable immunodeficiency
Kim, A. S., & Broide, D. H. (2016) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2016.11.009 · Cited by 7
Bilateral uveitis following intravenous immunoglobulin administration
Kocak, E. D., Wang, B. Z., & Hall, A. J. H. (2017) · American Journal of Ophthalmology Case Reports · doi:10.1016/j.ajoc.2017.03.005 · Cited by 7
Blood, Blood Components, Plasma, and Plasma Products
Opsha, Y., & Brophy, A. (2015) · Side effects of drugs annual · doi:10.1016/bs.seda.2015.05.003 · Cited by 7
Occurrence of acute renal failure on the same day as immune globulin product administrations during 2008 to 2014
Ekezue, B. F., Sridhar, G., Forshee, R. A., et al. (2017) · Transfusion · doi:10.1111/trf.14330 · Cited by 7
Hydroxyethyl starch and kidney function: A retrospective study in patients undergoing therapeutic plasma exchange
Muthuchellappan, R., Batra, A., Periyavan, S., Philip, M., & Anand, V. (2017) · Journal of Clinical Apheresis · doi:10.1002/jca.21598 · Cited by 7
Reversible Splenial Lesion Syndrome After Intravenous Immunoglobulin Treatment for Guillain-Barre Syndrome
Uygur-Kucukseymen, E., Yüksel, B., Genç, F. N., et al. (2017) · Clinical Neuropharmacology · doi:10.1097/wnf.0000000000000236 · Cited by 6
Intravenous immunoglobulin–induced acute thrombocytopenia
Gurevich‐Shapiro, A., Bonstein, L., Spectre, G., et al. (2017) · Transfusion · doi:10.1111/trf.14419 · Cited by 6
Assessment of Local Adverse Reactions to Subcutaneous Immunoglobulin (SCIG) in Clinical Trials
Ballow, M. C., Wasserman, R. L., Jolles, S. R. A., et al. (2017) · Journal of Clinical Immunology · doi:10.1007/s10875-017-0410-x · Cited by 5
Neurosurgery in a patient at peak levels of rivaroxaban: taking into account all factors
Vlieger, J. D., Dietvorst, S., Demaerel, R., Verhamme, P. B., Nuttin, B., & Vanassche, T. (2017) · Research and Practice in Thrombosis and Haemostasis · doi:10.1002/rth2.12035 · Cited by 5
Thrombosis of a Left Atrial Appendage Occluder After Treatment With Thrombopoietin Receptor Agonists
Cubero-Gallego, H., Romaguera, R., Teruel, L., et al. (2017) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2017.11.008 · Cited by 4
A Case of IVIG-Induced Aseptic Chemical Meningitis.
Patel, A. A., Potu, K. C., & Sturm, T. (2017) · PubMed · Cited by 4
Efficacy and Thrombotic Adverse Events of Romiplostim Use in Patients with Thrombocytopenia Related to Underlying Malignancies
Li, V. J., Miao, Y., Wilkins, C. R., et al. (2017) · Blood · doi:10.1182/blood.v130.suppl_1.2324.2324 · Cited by 4
Safety of bi-weekly intravenous therapy with alpha-1 antitrypsin
Greulich, T., Chlumský, J., Wencker, M., et al. (2017) · doi:10.1183/1393003.congress-2017.pa710 · Cited by 3
Change of coagulation after NovoSeven® use for bleeding during cardiac surgery
Tomita, E., Takase, H., Tajima, K., et al. (2017) · Asian Cardiovascular and Thoracic Annals · doi:10.1177/0218492317689901 · Cited by 2
A national French noninterventional study to assess the long‐term safety and efficacy of reformulated nonacog alfa
Lambert, T., Rothschild, C., Volot, F. G., et al. (2017) · Transfusion · doi:10.1111/trf.13988 · Cited by 2
Intraoperative hydroxyethyl starch 70/0.5 administration may increase postoperative bleeding: a retrospective cohort study
Fukushima, T., Uchino, S., Fujii, T., et al. (2017) · Journal of Anesthesia · doi:10.1007/s00540-017-2334-2 · Cited by 2
Phase II Study of Prophylactic Non-Irradiated Granulocyte Transfusions in AML Patients Receiving Induction Chemotherapy
Aung, F. M., Dinardo, C. D., Martínez, F. D., et al. (2017) · Journal of Blood Disorders & Transfusion · doi:10.4172/2155-9864.1000376 · Cited by 2
Blood, Blood Components, Plasma, and Plasma Products
Brophy, A., Opsha, Y., & Cardinale, M. (2016) · Side effects of drugs annual · doi:10.1016/bs.seda.2016.07.002 · Cited by 2
A Single Institutional Experience Comparing Cryoprecipitate to Plasma in Patients with Disseminated Intravascular Coagulopathy (DIC) from Acute Myeloid Leukemia (AML)
Abu-Zeinah, G. F., Al‐Kawaaz, M., Li, V. J., et al. (2017) · Blood · doi:10.1182/blood.v130.suppl_1.2409.2409 · Cited by 2
Commentary on: An objective measure of splitting in parental alienation: the Parental Acceptance‐Rejection Questionnaire. J Forensic Sci https://doi.org/10.1111/1556-4029.13625. Epub 2017 Aug 17
Puppo, V. (2018) · Journal of Forensic Sciences · doi:10.1111/1556-4029.13660 · Cited by 2

Research works printed but not linked: 3

Friesenecker, 2017, Deterioration of trauma induced coagulopathy during massive transfusion with fresh frozen plasma, Trauma Acute Care, 2, 1
Bentzer, 2017, Effect of dextran-70 on outcome in sever sepsis; a propensity-score matching study, Scand J Trauma Resusc Emerg Med, 25, 1
Cardinale, 2017, Chapter 29 - Blood, Blood Components, Plasma, and Plasma Products, 39, 331

In-Vitro and In-Silico Assessment of Per- and Polyfluoroalkyl Substances (PFAS) in Aqueous Film-Forming Foam (AFFF) Binding to Human Serum Albumin
Li, W., Hu, Y., & Bischel, H. N. (2021) · Toxics · doi:10.3390/toxics9030063 · Cited by 53

See all 4

Authors: Sobolewski, K. A., Radparvar, S., Wong, C., & Johnston, J. P.
Affiliations: Saint Barnabas Medical Center (US)
Rutgers, The State University of New Jersey (US)
Corresponding author: Kristine A. Sobolewski
ORCID: Sara Radparvar
Jackie P. Johnston
Venue: Side Effects of Drugs Annual
Publisher: Elsevier
Published: 2018
Pages: 415-429
ISSN: 0378-6080 (ISSN-L)
DOI: 10.1016/bs.seda.2018.06.011
OpenAlex: W2889675507
Cited by: 4
References: 109
Citations by year: 2026: 1 · 2023: 2 · 2021: 1
FWCI: 0.36
Type: book chapter
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: Side effects of drugs annual (publishedVersion)
Topics: Health Sciences › Medicine › Hematology › Blood transfusion and management
Health Sciences › Medicine › Hematology › Blood donation and transfusion practices
Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Trauma, Hemostasis, Coagulopathy, Resuscitation
Keywords: blood products, blood transfusion, plasma-derived products, blood substitutes, hemoglobin-based oxygen carriers, transfusion-transmitted infections, blood donation, intravenous immunoglobulin, cryoprecipitate, fresh frozen plasma, coagulation factors, erythropoietin, thrombopoietin, stem cells, albumin, alpha-1-antitrypsin, C1 esterase inhibitor concentrate, plasma expanders, dextran, gelatin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

Blood, Blood Components, Plasma, and Plasma Products

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks

Data sources